Abstract: The new technologies in the health area have profoundly impacted the doctrine of informed consent, creating the need for a detailed investigation, on the contours and dynamics of this new model of the patient to consent to any treatments or medical interventions. The digitization of the health sector was a paramount factor in making it possible to implement artificial intelligence in support of clinical decision and in the efficiency of medical diagnoses, especially in the early detection of diseases, in view of their ability to process and analyze quickly - and in an efficient and effective way - large amount of data. In recent years, there has been a significant expansion of artificial intelligence combined with robotics, creating a reality of intelligent assistance robots for medical care. The global market for surgical robots, which perform procedures face-to-face or remotely (tele-surgery) has also grown rapidly in recent years. Finally, the technological revolution in the health sector has allowed doctors to diagnose, treat and even perform surgeries on remote patients, in the most remote places in the world, through Telemedicine. In view of all the current panora- ma of digitalized medicine and new technologies in the health field - telemedicine, robotic medicine and artificial intelligence -, we were able to observe, throughout the present work, that the informed consent of the patient acquires certain peculiarities, considering the diverse random factors and risks inherent to the unique characteristics of each technology. In conclusive lines, we found that the modern dogmatic of informed consent encompasses the idea of an informed choice, since the patient must be in possession of all the information and possible elements for his understanding. In other words, more than a right to information, the patient has a right to explanation and justification, in order to consent in a free and informed manner.